LVPEI Study: CXL Safe for High-Risk Keratoconus Patients
A new study from LV Prasad Eye Institute finds collagen crosslinking (CXL) is effective and safe for keratoconus patients, even those with limbal stem cell damage from severe eye allergies. Learn more about this breakthrough.